Prévisions du marché européen de l’immunohistochimie jusqu’en 2028 – Impact du COVID-19 et analyse régionale par application (diagnostics et tests de médicaments), produit (anticorps, équipements, réactifs et kits) et utilisateur final (hôpitaux et laboratoires de diagnostic, instituts de recherche et autres)

Introduction au marché

L\'Europe est le deuxième plus grand marché pour l\'immunohistochimie, suivi du Royaume-Uni, de l\'Allemagne, de la France, de l\'Italie, de l\'Espagne et du reste. d\'Europe sont les principaux contributeurs à ce marché dans cette région. L\'Allemagne a dominé le marché au cours de la période de prévision. L\'Allemagne a connu une augmentation considérable des cas de cancer ces dernières années ; par exemple, selon l\'Observatoire mondial du cancer, en 2020, un total de 6 28 519 nouveaux cas ont été découverts chez les deux sexes et tous les âges, ainsi que 69 697 (11,1%) cas de cancer du sein, 67 959 (10,8%) Cancer de la prostate, 64 804 (10,3 %) Cancer du poumon, 57 528 (9,2 %) Cancer colorectum, 35 147 (5,6 %) Cancer de la vessie et 333 384 (53 %) Autres cancers. L\'immunohistochimie est largement utilisée dans le diagnostic et la gestion du cancer ; ainsi, la demande en immunohistochimie augmente dans le pays. La prévalence des maladies cardiovasculaires augmente dans le pays. La population âgée contribue largement à l’augmentation de la prévalence des maladies cardiovasculaires. Les changements démographiques créent des défis majeurs pour les soins aux patients. Le nombre de maladies chroniques augmente également de manière constante, parallèlement à une population de plus en plus vieillissante. Dans le même temps, la pression sur les coûts dans le secteur de la santé s’accentue. Comme l’indique l’Institut Max Planck 2019, environ 30 à 40 % des adultes souffrent d’hypertension artérielle dans le pays. L\'incidence augmente avec l\'âge et les personnes de plus de 60 ans sont plus susceptibles de développer une maladie cardiovasculaire. L\'IHC devient de plus en plus populaire dans le domaine du diagnostic clinique car il est utilisé pour diagnostiquer des maladies chroniques telles que le cancer, les maladies infectieuses, les maladies cardiovasculaires et les maladies auto-immunes. Par conséquent, la prévalence croissante des maladies chroniques devrait accroître la demande de solutions immunohistochimiques, favorisant ainsi la croissance du marché.

Les pays d\'Europe, en particulier la France, sont fortement touchés en raison de l\'épidémie de COVID-19. Les anticorps immunohistochimiques du coronavirus sont des méthodes immunologiques qui peuvent être utilisées pour identifier les membres de la famille des virus à ARN Coronaviridae qui infectent les oiseaux et les mammifères. Les anticorps contre les antigènes exprimés par plusieurs souches de coronavirus, telles que le SRAS-CoV-2, le SRAS-CoV, le MERS et d’autres agents pathogènes non humains comme le coronavirus félin, sont répertoriés ci-dessous. Les cibles courantes des anticorps contre les coronavirus comprennent la nucléocapside (N) et la glycoprotéine de pointe (S). Ces anticorps sont destinés à des applications immunohistochimiques. L’analyse immunohistochimique montre la détection de niveaux d’expression différentiels de la nucléocapside du coronavirus SARS-CoV-2 et démontre la spécificité des anticorps. L\'analyse immunohistochimique du NP du coronavirus SARS-CoV-2 à l\'aide de l\'anticorps monoclonal NP du coronavirus SARS/SARS-CoV-2 (B46F) (n° de catalogue MA1-7404) montre une coloration significative dans les tissus pulmonaires et placentaires humains infectés par le SRAS-CoV-2. par rapport aux tissus témoins sans SRAS-CoV-2. Des chercheurs du Royaume-Uni et de Suède ont récemment utilisé l\'immunohistochimie multiplexée extrêmement sensible pour examiner l\'expression de l\'ACE2 dans les péricytes cérébraux de patients présentant des symptômes neurologiques chez des patients atteints de COVID-19 et des témoins. Ils ont également utilisé l\'immunophénotypage spatial pour évaluer l\'inflammation dans les tissus cérébraux des patients atteints de COVID-19.

Aperçu et dynamique du marché

Le Le marché européen de l\'immunohistochimie devrait passer de 631,33 millions de dollars US en 2021 à 1 022,27 millions de dollars US d\'ici 2028 ; on estime qu\'il augmentera à un TCAC de 7,1 % de 2021 à 2028. Les tests de diagnostic traditionnels étaient généralement effectués dans des laboratoires dotés d\'équipements coûteux et dotés d\'un personnel qualifié chargé d\'effectuer les tests. Depuis les dernières décennies, les tests de diagnostic ont progressivement progressé du laboratoire central vers des sites de test proches des patients. La demande croissante en immunohistochimie, associée à une pénurie de personnel dans les laboratoires d’immunologie, a créé un besoin d’automatisation dans le domaine de l’immunohistochimie. L\'automatisation en immunohistochimie (IHC) offre la possibilité d\'améliorer les niveaux de sensibilité, la reproductibilité, la standardisation, et offre des avantages tels qu\'une réduction du temps de travail et une économie de réactifs. La flexibilité analytique est l’un des facteurs essentiels requis dans les protocoles d’immunohistochimie. L’automatisation de l’IHC contribue à standardiser de manière décisive les techniques immunohistochimiques. De plus, cela permet également de simplifier les méthodes manuelles en 16 étapes en méthodes en 5 étapes qui permettent de minimiser le nombre de personnes travaillant. De plus, l’immunohistochimie automatisée garantit une qualité et une élimination constantes des colorants et améliore la standardisation et l’optimisation des différentes techniques. De plus, avec des résultats fiables et rapides, l’automatisation peut fournir des résultats de tests de diagnostic plus rapidement, ce qui permet de raccourcir la période d’hospitalisation, ce qui entraîne des économies. Ainsi, les divers avantages offerts par l\'automatisation en immunohistochimie (IHC) seront probablement acceptés et constitueront l\'une des tendances dominantes sur le marché européen au cours des années à venir.

Segments clés du marché

En termes de produit, le segment des anticorps représentait la plus grande part du marché européen de l\'immunohistochimie en 2020. En termes d\'application, le segment des diagnostics détenait une part de marché plus importante de le marché européen de l\'immunohistochimie en 2020. En outre, le segment des hôpitaux et des laboratoires de diagnostic détenait une part plus importante du marché européen de l\'immunohistochimie en fonction de l\'utilisateur final en 2020.

Principales sources et entreprises

Quelques principales sources primaires et secondaires mentionnées pour la préparation de ce rapport sur le marché européen de l\'immunohistochimie sont les sites Web des entreprises, les rapports annuels, les rapports financiers, les documents gouvernementaux nationaux et les statistiques. base de données, entre autres. Les principales sociétés répertoriées dans le rapport sont Abcam plc ; Agilent Technologies, Inc. ; Bio SB ; LABORATOIRES BIO-RAD INC.; Technologie de signalisation cellulaire, Inc. ; Danaher ; F. HOFFMANN-LA ROCHE LTÉE; MERCK KGaA ; PerkinElmer Inc. ; et THERMO FISHER SCIENTIFIC INC.

Rapport sur les raisons d\'acheter

Comprendre le paysage du marché européen de l\'immunohistochimie et identifier les segments de marché les plus susceptibles de garantir un fort retour
Gardez une longueur d\'avance sur la course en comprenant l\'évolution constante paysage concurrentiel pour le marché européen de l\'immunohistochimie
Planifier efficacement les fusions et acquisitions et les accords de partenariat sur le marché européen de l\'immunohistochimie en identifiant les segments de marché avec les ventes probables les plus prometteuses
Aide à prendre des décisions commerciales éclairées de manière perspicace et analyse complète des performances du marché de divers segments du marché européen de l\'immunohistochimie
Obtenez les prévisions de revenus du marché pour le marché par divers segments de 2021 à 2028 dans la région Europe.

Segmentation du marché européen de l\'immunohistochimie

Marché européen de l\'immunohistochimie - Par produit

Équipement
- Systèmes de coloration de lames
- Systèmes de micropuces de tissus
- Systèmes de traitement des tissus
- Scanners de lames
- Autres équipements
Anticorps
- Anticorps primaires
- Anticorps secondaires
Réactifs
- Colorations histologiques
- Réactifs de blocage et de fixation
- Substrats chromogènes
- Réactifs de fixation
- Stabilisants
- Solvants organiques
- Enzymes protéolytiques
- Diluants
Kits

Marché européen de l\'immunohistochimie - Par application

Diagnostic
- Cancer
- Maladies infectieuses
- Maladies auto-immunes
- Diabète sucré
- Maladies néphrologiques
- Autres
Dépistage de drogues

Marché européen de l\'immunohistochimie - Par utilisateur final

Hôpitaux et laboratoires de diagnostic
Instituts de recherche
Autres

Marché européen de l\'immunohistochimie – Par pays

Marché européen de l\'immunohistochimie - Profils d\'entreprises

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Immunohistochemistry Market – By Product

1.3.2 Europe Immunohistochemistry Market – By Application

1.3.3 Europe Immunohistochemistry Market – By End User

1.3.4 Europe Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidences of Chronic and Infectious Diseases

5.1.2 Growing R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Issues Related to Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Opportunities in Several Countries

5.4 Future Trends

5.4.1 Use of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – Europe Analysis

6.1 Europe Immunohistochemistry Market Revenue Forecast and Analysis

7. Europe Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 Europe Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. Europe Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. Europe Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 Europe Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. Europe Immunohistochemistry Market – Country Analysis

10.1 Europe: Immunohistochemistry Market Revenue and Forecasts to 2028

10.1.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.1.2.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.1.2.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.1.2.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.1.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.1.3.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.1.4 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.2.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.2.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.2.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.2.3.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.2.4 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.3 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.3.2.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.3.2.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.3.2.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.3.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.3.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.3.4 France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.4.2.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.4.2.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.4.2.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.4.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.4.3.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.4.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.5 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.5.2.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.5.2.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.5.2.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.5.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.5.3.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.5.4 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.6 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.6.2.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.6.2.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.6.2.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.6.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.6.3.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.6.4 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on Europe Immunohistochemistry Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 Cell Signaling Technology, Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 MERCK KGaA

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 PerkinElmer Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 THERMO FISHER SCIENTIFIC INC.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Abcam plc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 BIO-RAD LABORATORIES INC.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Danaher

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Bio SB

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 4. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 5. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 7. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 8. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 9. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 11. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 12. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 14. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 15. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 16. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 18. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 19. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 21. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 22. France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 23. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 25. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 26. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 28. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 29. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 30. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 31. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 32. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 33. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 34. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Application (USD Million)

Table 35. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Diagnostics (USD Million)

Table 36. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by End User (USD Million)

Table 37. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 38. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 39. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 40. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 41. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 42. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 43. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 44. Organic Developments Done By Companies

Table 45. Inorganic developments done by Companies

Table 46. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Immunohistochemistry Market Segmentation

Figure 2. Europe Immunohistochemistry Market Segmentation, By Country

Figure 3. Europe Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. The UK to Show Significant Growth During Forecast Period

Figure 6. Europe and PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to Europe Immunohistochemistry Market

Figure 8. Europe Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. Europe Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. Europe Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Europe Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. Europe Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. Europe Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Europe Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Europe Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. Europe Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Europe Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. Europe Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. Europe Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. Europe Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. Europe Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. Europe Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. Europe Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. Europe Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. Europe Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. Europe Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. Europe Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. Europe Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. Europe Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. Europe Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. Europe Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. Europe Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. Europe Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. Europe Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. Europe Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. Europe Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. Europe Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. Europe Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. Europe Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. Europe Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. Europe: Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 43. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. Germany Immunohistochemistry Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48. Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 49. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 50. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe immunohistochemistry market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample